Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus versus placebo in advanced gastrointestinal or lung neuroendocrine tumors without carcinoid symptoms
NL-OMON37366Phase 3Active, not recruiting
- Sponsor
- Novartis
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in apudoma (NET), sponsored by Novartis. Started Mar 2012; status: active, not recruiting.
02
Drugs
everolimus
03
Conditions
apudoma (NET)
Beyond the preview
Go deeper on NL-OMON37366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37366.